Im cautiously optimistic, said Meghan Garcia-Webb, MD, triple board certified in internal medicine, lifestyle medicine, and obesity medicine
Hence, empagliflozin is not commonly used as a routine treatment for type 1 diabetes but is mainly approved to treat type 2 diabetes
Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease
For these patients, greater muscle loss was also tied to weaker improvements in their blood sugar, measured through HbA1c levelsa key marker for blood sugar control over time
instead, they are produced under FDA regulatory oversight by licensed 503A compounding pharmacies
No social factors clearly contributed to poor adherence